论文部分内容阅读
目的比较分析腔内等离子汽化切割系统行治疗良性前列腺增生(Benign prostatic hyperplasia,BPH)的两种术式:经尿道等离子前列腺电切术(Transurethral plasmakinetic resction of prostate,TUPKP)与经尿道等离子汽化剜切术(Tansurethral vpor Enucleation rsection of the prostate,TVERP)的临床疗效。方法回顾性分析2009年10月至2014年11月在某院行TUPKP和TVERP治疗的良性前列腺增生的病例资料,其中TUPKP组70例,TVERP组46例。通过手术操作用时、术中失血量、切除腺体体积、术后膀胱持续冲洗时间和并发症机率评价两种手术方式围手术期安全性;通过比较术后3个月前列腺症状主观及客观评分表、尿流动力学指标评价两种手术方式的疗效。结果两组数据比较TVERP治疗组术中出血量、术后膀胱冲洗时间相对低、前列腺切除重量相对高、并发症机率低(P<0.05);术后3个月两组最大尿流率(Qmax)、残尿量(PRV)、国际前列腺症状评分(IPSS)、生活质量评分(QOL)较术前均明显改善,但两组间比较差异无显著性(P>0.05)。结论经尿道等离子汽化剜切术治疗前列腺增生手术安全性更好,短期疗效与等离子前列腺电切术相当,是一种治疗良性前列腺增生相对理想的手术方法。
OBJECTIVE: To compare two methods of treatment of benign prostatic hyperplasia (BPH) by transvaginal plasmaphototomy (TUPKP) and transurethral plasmapheresis (Tansurethral vpor Enucleation rsection of the prostate, TVERP) clinical efficacy. Methods The clinical data of TUPKP and TVERP treated benign prostatic hyperplasia in a hospital from October 2009 to November 2014 were retrospectively analyzed. Among them, 70 were in the TUPKP group and 46 in the TVERP group. The perioperative safety of the two surgical methods was evaluated by the time of operation, blood loss during operation, the volume of resected glands, the duration of postoperative bladder irrigation and the probability of complications. By comparing the subjective and objective scores of prostate symptoms at 3 months postoperatively , Urodynamic indicators to evaluate the efficacy of the two surgical methods. Results The data of two groups were compared in the amount of bleeding, the duration of postoperative bladder irrigation, the relatively high prostate resection weight, and the low complication rate (P <0.05). The maximum blood flow rate (Qmax ), Residual urine volume (PRV), International Prostate Symptom Score (IPSS) and Quality of Life Scale (QOL) were significantly improved compared with those before operation. There was no significant difference between the two groups (P> 0.05). Conclusions Transurethral vaporization and resection of the prostate for benign prostatic hyperplasia is more safe and short-term efficacy is equivalent to plasma prostatectomy. It is a relatively ideal surgical method for the treatment of benign prostatic hyperplasia.